Glycemic Targets and Glucose Monitoring.
A(1c)
Continuous glucose monitoring
GMI
Glucose management indicator
Glycemia
Glycemic targets
Hypoglycemia
Self-monitoring of blood glucose
Journal
Primary care
ISSN: 1558-299X
Titre abrégé: Prim Care
Pays: United States
ID NLM: 0430463
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
entrez:
20
5
2022
pubmed:
21
5
2022
medline:
25
5
2022
Statut:
ppublish
Résumé
Assessing glycemia over time remains a standard recommendation in the care of all people with diabetes. Glycemic assessment methods range from laboratory- and office-based methods to patient-based methods. Assessing A1c has long been the most common method of assessing overall glycemia. Continuous glucose monitoring (CGM) can also be used, especially via glucose management indicator or time-in-range, which can be useful especially when A1c might be impractical, unreliable, or inaccurate, or for glycemia assessment over a shorter interval. Other measures of glycemia, including hypoglycemia and glycemic variability, are becoming increasingly important in many cases and are also available via CGM.
Identifiants
pubmed: 35595478
pii: S0095-4543(21)01632-8
doi: 10.1016/j.pop.2021.11.002
pii:
doi:
Substances chimiques
Blood Glucose
0
Glycated Hemoglobin A
0
Hypoglycemic Agents
0
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
213-223Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.